NEWS

For our visitors who seek the latest industry news and updates to keep abreast with the goings-on of the business on a global scale, Pharmaceutical Industry portal grants a dynamic and diverse feed of news items.

news

Drug firm Jubilant Life Sciences has received approval from the US health regulator for generic Irbesartan and Cetirizine Hydrochloride tablets used for treatment of hypertension and allergies respectively. The company has received final approval from US Food and Drug Administration for its abbreviated new drug application for Irbesartan tablets in…

news

Pharmaceutical firm Horizon Pharma today announced 60 new jobs at the official opening of its global headquarters in Dublin. The positions will be created in the areas of Research and Development, supply chain and finance, over the next three years. Horizon Pharma chief executive Timothy Walbert said Dublin has a…

news

Intas Pharmaceuticals has launched its first biosimilar product, Accofil, used in treating immune system disorders, in European markets. The company has launched its first biosimilar, filgrastim, in Europe through its wholly-owned subsidiary Accord Healthcare, Intas Pharmaceuticals said in a statement. The product has recently been introduced under the brand Accofil…

news

Sun Pharma is voluntarily recalling 3,263 bottles of Levetiracetam, extended release tablets, an anti epileptic drug, in the US market. As per the information available on the USFDA website, Sun Pharma Global Fze, a US-based unit of the company, is recalling the drug for failing "dissolution specifications". The 750 mg…

news

Shire plc announces the successful completion of the tender offer for all of the outstanding shares of NPS Pharmaceuticals, Inc. and the subsequent acquisition of NPS Pharma. The tender offer expired at 12:00 midnight, New York City time, at the end of Friday, February 20, 2015, and was not extended.…

news

Leading brokerage Motilal Oswal's private equity arm today said it has invested Rs 40 crore in pharma player Arinna Lifesciences which will be used for expanding the market and product line. The India Business Excellence Fund II and India Business Excellence Fund II-A, managed by Motilal Oswal Private Equity, have…

news

Granules-OmniChem Private Ltd. today inaugurated their manufacturing facility for high-value active pharmaceutical ingredients (APIs) and intermediates. The company is a joint venture between Granules India Ltd., a pharmaceutical manufacturing company and Ajinomoto OmniChem, a leading producer of fine chemicals. The plant was inaugurated by M Venkaiah Naidu, Union Minister for…

news

M Pharmaceutical Inc., announces that it has finalized the acquisition of the intellectual property associated with the eMosquito by the purchase of M Diagnostics Inc., a private company. The Company paid US$ 150,000 on closing, agreed to pay a 3% royalty on the commercial sale of any related products, and…

news

Catalyst Pharmaceutical Partners, Inc., a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases, today announced the appointment of Richard J. Daly and Donald A. Denkhaus to the Company's Board of Directors. "Catalyst is pleased to welcome such exceptional and successful pharmaceutical business leaders…

news

A UK Pharmaceutical Company signs a contract with Formpipe regarding an Enterprise Compliance Platform, to manage their quality and product documentation. Says total order value amounts to 1.2 million Swedish crowns ($143,558) over three years Says of total order value, license revenues of 0.6 million crowns, are recorded in Q1…